Registered entities
Seraphina Therapeutics Inc
Reg. No. 81-5016406United States
Investor mix
5 investors on record; lead investors include Domain Associates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 2 | 40% |
US-based preclinical stage biopharma developing a lipid based therapeutic for cardiometabolic disease
5 investors on record; lead investors include Domain Associates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 2 | 40% |